These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8669861)

  • 1. CD-44 is not involved in the metastatic spread of ovarian cancer in vivo.
    Speiser P; Wanner C; Breitenecker G; Kohlberger P; Kainz C
    Anticancer Res; 1995; 15(6B):2767-9. PubMed ID: 8669861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the CD44 glycoprotein (lymphocyte-homing receptor) in untreated human breast cancer and its relationship to prognostic markers.
    de la Torre M; Heldin P; Bergh J
    Anticancer Res; 1995; 15(6B):2791-5. PubMed ID: 8669866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo inhibition of CD44 limits intra-abdominal spread of a human ovarian cancer xenograft in nude mice: a novel role for CD44 in the process of peritoneal implantation.
    Strobel T; Swanson L; Cannistra SA
    Cancer Res; 1997 Apr; 57(7):1228-32. PubMed ID: 9102203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional heterogeneity of CD44 molecules in ovarian cancer cell lines.
    Cannistra SA; DeFranzo B; Niloff J; Ottensmeir C
    Clin Cancer Res; 1995 Mar; 1(3):333-42. PubMed ID: 9815989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splice variant expression of CD44 in patients with breast and ovarian cancer.
    Sanchez Lockhart M; Hajos SE; Basilio FM; Mongini C; Alvarez E
    Oncol Rep; 2001; 8(1):145-51. PubMed ID: 11115587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD44(v5-10) splicing variants in primary ovarian cancer and lymph node metastases.
    Schröder W; Rudlowski C; Biesterfeld S; Knobloch C; Hauptmann S; Rath W
    Anticancer Res; 1999; 19(5B):3901-6. PubMed ID: 10628329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck.
    Herold-Mende C; Seiter S; Born AI; Patzelt E; Schupp M; Zöller J; Bosch FX; Zöller M
    J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
    Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
    Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 modulates Hs578T human breast cancer cell adhesion, migration, and invasiveness.
    Herrera-Gayol A; Jothy S
    Exp Mol Pathol; 1999 Apr; 66(1):99-108. PubMed ID: 10331969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear cell carcinoma of the ovary: characterization of its CD44 isoform repertoire.
    Sancho-Torres I; Mesonero C; Miller Watelet JL; Gibbon D; Rodríguez-Rodríguez L
    Gynecol Oncol; 2000 Nov; 79(2):187-95. PubMed ID: 11063642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survival.
    Kayastha S; Freedman AN; Piver MS; Mukkamalla J; Romero-Guittierez M; Werness BA
    Clin Cancer Res; 1999 May; 5(5):1073-6. PubMed ID: 10353740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.
    Voutilainen KA; Anttila MA; Sillanpää SM; Ropponen KM; Saarikoski SV; Juhola MT; Kosma VM
    J Clin Pathol; 2006 May; 59(5):460-7. PubMed ID: 16461565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD44 alternative splicing variants in primary and lymph node metastatic lesions of gynecological cancer.
    Yorishima T; Nagai N; Ohama K
    Hiroshima J Med Sci; 1997 Mar; 46(1):21-9. PubMed ID: 9114564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and expression of CD44 isoforms and Ezrin during prostate cancer-endothelium interaction.
    Harrison GM; Davies G; Martin TA; Jiang WG; Mason MD
    Int J Oncol; 2002 Nov; 21(5):935-40. PubMed ID: 12370738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice.
    Fichtner I; Dehmel A; Naundorf H; Finke LH
    Anticancer Res; 1997; 17(5A):3633-45. PubMed ID: 9413216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer.
    Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Cosio S; Prontera C; Bianchi R; Genazzani AR
    Anticancer Res; 1997; 17(6D):4463-6. PubMed ID: 9494551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of p53, Ki-67, and CD44v6 expression between primary and matched metastatic lesions in ovarian cancer.
    Sakai K; Kaku T; Kamura T; Kinukawa N; Amada S; Shigematsu T; Hirakawa T; Kobayashi H; Ariyoshi K; Nakano H
    Gynecol Oncol; 1999 Mar; 72(3):360-6. PubMed ID: 10053108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
    Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
    Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines.
    Stickeler E; Runnebaum IB; Möbus VJ; Kieback DG; Kreienberg R
    Anticancer Res; 1997; 17(3C):1871-6. PubMed ID: 9216637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intron 9 retention in gene transcripts suggests involvement of CD44 in the tumorigenesis of ovarian cancer.
    Stickeler E; Möbus VJ; Kieback DG; Kohlberger P; Runnebaum IB; Kreienberg R
    Anticancer Res; 1997; 17(6D):4395-8. PubMed ID: 9494539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.